FY26 Annual General MeetingChief Executive Officer: Anne-Louise Arnett19 October 2026Chair: Jayne ShawCEO’s AddressAn Australian health care company pioneering diagnostics for earlier cancer detectionClose the gaps in early cancer detection.Our PurposeExpand early diagnostic access by creating...
AGM 2026 Presentation
Filed with ASX · · 19 pages · English
Release
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- BREASTESTplus Research Presented at Lipidomic Conference
- GSS: Response to Media Speculation & BCAL letter to GSS
- Letter to Genetic Signatures Ltd Shareholders
- Investor Presentation - Transforming Cancer Detection
- Change in substantial holding
Later from BCAL Diagnostics
- Results of Meeting
- BCAL Welcomes Dr John Melki's Appointment to GSS Board
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics